Related Experiment Videos
Five-year mortality in lithium-treated manic-depressive patients.
1Clinical Department A, Psychiatric Hospital, Risskov, Denmark.
Journal of Affective Disorders
|January 1, 1991
Summary
Lithium treatment for affective disorders showed higher mortality rates than expected, with suicides occurring in younger patients. Comprehensive care programs are recommended for better patient outcomes.
Area of Science:
- Psychiatry
- Clinical Pharmacology
Background:
- Affective disorders pose significant mortality risks.
- Prophylactic lithium treatment is a common intervention for mood stabilization.
Purpose of the Study:
- To prospectively evaluate the 5-year mortality in patients with affective disorders receiving prophylactic lithium.
- To identify risk factors associated with mortality in this patient cohort.
Main Methods:
- Prospective follow-up of 133 patients with affective disorders on lithium treatment for 5 years.
- Recording and analysis of mortality data, including causes of death (natural vs. suicide).
Main Results:
- Overall mortality was significantly higher than expected.
- Suicide accounted for nine deaths, primarily in bipolar or uncertain polarity affective disorder patients.
- No deaths were attributed to lithium toxicity or side effects.
- Suicide victims were younger, more socially isolated, and died violently.
- Natural cause deaths were associated with pre-existing physical illness and alcohol abuse.
Conclusions:
- Prophylactic lithium treatment in affective disorders is associated with elevated mortality.
- Comprehensive treatment programs, potentially within specialized clinics, are crucial for managing patients with affective disorders.
- Further research into risk stratification and targeted interventions for suicide prevention in this population is warranted.